EUCTR2020-005721-82-NL进行中（未招募）1 期
The Gout TrEatment STrategy Project (GO TEST) Overture trial - GO TEST OVERTURE
VieCuri0 个研究点目标入组 310 人开始时间: 2021年1月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 310
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with a Cclinical diagnosis of gout and/or fulfilling the 2015 ACR-EULAR criteria
- •Hyperuricemia
- •No current use of ULT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 310
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 310
排除标准
- •A strong Contraindication for all allopurinol, benzbromarone AND febuxostat ULT
- •Kidney failuree defined as GFR < 30ml/minute
- •Insufficient mastery of Dutch language to fill out questionnaires
研究者
相似试验
招募中
不适用
The Gout TrEatment STrategy Project (GO TEST) Overture trialGouty arthritisGout10023213NL-OMON55282Viecuri Medisch Centrum voor Noord-Limburg310
进行中（未招募）
1 期
Research into continuation or cessation of urate lowering therapies in gout patients in remission.EUCTR2020-005730-15-NLSint Maartenskliniek310
已完成
Unknown
GOut TrEatment STrategy (GO TEST) FINALE study continuation versus cessation of urate lowering therapies in gout in remission.<p>Gout, arthritis urica</p>Inflammatory rheumatic disease, gout10023213NL-OMON20243Sint Maartenskliniek, Nijmegen310
进行中（未招募）
1 期
GO TEST FINALEGoutMedDRA version: 20.0Level: LLTClassification code: 10003257Term: Arthritis gouty Class: 10028395MedDRA version: 21.0Level: LLTClassification code: 10003435Term: Articular gout Class: 10027433MedDRA version: 20.0Level: PTClassification code: 10018627Term: Gout Class: 100000004861MedDRA version: 21.1Level: LLTClassification code: 10064900Term: Gout flare Class: 10027433CTIS2024-511111-13-01Sint Maartenskliniek310
招募中
不适用
GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre, pragmatic, randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission.NL-OMON52436Sint Maartenskliniek310